SEN-JAM PHARMACEUTICAL
Sen-Jam Pharmaceutical is a medical company developing novel pharmaceutical solutions for large unmet needs using the development pathway. The company focused on improving clinical outcomes for patients battling opioid use disorder, viral respiratory infections from coronaviruses such as COVD-19 and other painful inflammation and toxin-induced conditions, including arthritis, vaccinations, and even the infamous hangover. Sen-Jam Pharmaceutical develops consumer healthcare products that help peo... ple stay strong by mitigating common side effects from medicines and everyday living. The company global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. Sen-Jam Pharmaceutical was founded in 2014 and is headquartered in Huntington, New York, United States.
SEN-JAM PHARMACEUTICAL
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2014-01-01
Address:
Huntington, New York, United States
Country:
United States
Website Url:
http://www.sen-jam.com
Total Employee:
11+
Status:
Active
Contact:
201.400.8083
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Apache Wordpress Plugins
Similar Organizations
Acuity Pharmaceuticals
Acuity Pharmaceuticals product-focused ophthalmic pharmaceutical company applying its proprietary technology to the treatment.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Employees Featured
Founder
Investors List
StartUp Health
StartUp Health investment in Seed Round - Sen-Jam Pharmaceutical
Official Site Inspections
http://www.sen-jam.com Semrush global rank: 5.24 M Semrush visits lastest month: 1.56 K
- Host name: ip-173-201-186-91.ip.secureserver.net
- IP address: 173.201.186.91
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Sen-Jam Pharmaceutical"
About - Sen-Jam Pharmaceutical
Sen-Jam collaborates with visionary partners across science, distribution, and licensing. Together, we are building a future where healthcare moves upstream—preserving vitality, productivity, … See details»
Sen-Jam Pharmaceutical - Crunchbase Company …
Sen-Jam Pharmaceutical is a medical company developing novel pharmaceutical solutions for large unmet needs using the development pathway. See details»
Neal Zahn - Director of Global Licensing - Sen-Jam
Neal Zahn is a serial entrepreneur who joined forces with Sen-Jam Pharmaceutical in 2021 and currently serves as the Director of Global … See details»
Sen-JamPharmaceutical: Revolutionizing Healthcare by …
Sen-JamPharmaceutical: Revolutionizing Healthcare by Transforming Inflammation Treatment Sen-Jam Pharmaceutical, founded in 2017 and based in Huntington, New York, is co-led by … See details»
Sen-Jam Pharmaceutical Secures Financial and Strategic …
Jan 22, 2025 Sen-Jam Pharmaceutical, a leader in innovative solutions targeting inflammation and metabolic health, proudly announces a financial and strategic investment from 5 Horizons … See details»
Sen-Jam: Pioneering Anti-Inflammatory Solutions
Mar 26, 2024 Discover how Sen-Jam Pharmaceutical is transforming healthcare with groundbreaking therapeutics to treat inflammation. In this Founder Profile, co-founder Jacqueline Iversen shares the journey of tackling a $217B market … See details»
Sen-Jam Pharmaceutical – Connectpreneur
Sen-Jam Pharmaceutical A disruptor of the $1.5T inflammation market with proven assets, bold IP, and a high-impact leadership team. Christine Leonard, Head of Strategic Communications … See details»
Sen-Jam Pharmaceutical - VentureRadar
"Sen-Jam Pharmaceutical’s mission is to improve the lives of others by creating proprietary products that are efficacious, safe, and accessible by all. We make therapeutics that reduce … See details»
Sen-Jam Pharmaceutical Advances First in Class FDA-Regulated …
Nov 19, 2024 About Sen-Jam Pharmaceutical Sen-Jam Pharmaceutical is a drug innovation company dedicated to improving societal wellbeing by developing novel solutions for pain and … See details»
Invest in Sen-Jam Pharmaceutical: Inflammation …
Sen-Jam is a next-gen pharma platform aiming to reshape how the world treats inflammation—and how the pharmaceutical industry treats people. We want to be an end to pharma as perpetuating sick care and ignite an era of healthspan … See details»
Sen-Jam Pharmaceutical Revolutionizing Inflammatory …
Sen-Jam Pharmaceutical is focused on improving clinical outcomes for patients battling opioid use disorder and other painful inflammation and toxin-induced conditions. See details»
Invest in Sen-Jam Pharmaceutical
Sen-Jam Pharmaceutical is focused on improving clinical outcomes for patients battling opioid use disorder, viral respiratory infections from coronaviruses such as COVID-19 and other painful … See details»
Jacqueline Iversen’s Visionary Approach with innovative Pain …
Oct 18, 2024 Jacqueline Iversen is transforming the pharmaceutical industry with proactive, low-cost solutions for pain management and wellness Jacqueline Iversen, co-founder of Sen-Jam … See details»
Sen-Jam Pharmaceutical - Funding, Financials, Valuation & Investors
Jan 22, 2025 Sen-Jam Pharmaceutical is a medical company developing novel pharmaceutical solutions for large unmet needs using the development pathway. See details»
Sen-Jam Pharmaceutical Advances First in Class FDA-Regulated …
Nov 19, 2024 Sen-Jam Pharmaceutical announced recently the initiation of a Phase 2 clinical trial for SJP-001, positioning it to become the first FDA-approved therapeutic specifically … See details»
Sen-Jam Pharmaceutical Secures Financial and Strategic Investment
May 2, 2025 HUNTINGTON, N.Y., Jan. 22, 2025 /PRNewswire/ — Sen-Jam Pharmaceutical, a leader in innovative solutions targeting inflammation and metabolic health, proudly announces … See details»
Jim Iversen - Sen-Jam Pharmaceutical | LinkedIn
Jim is an accomplished entrepreneur and seasoned executive, passionate about improving… · Experience: Sen-Jam Pharmaceutical · Education: NJIT · Location: Huntington · 500+ … See details»
Sen-Jam Pharmaceutical Secures Financial and Strategic …
Jan 22, 2025 Horizon, as the lead investor for the Phase 2 clinical trial of SJP-001, Sen-Jam’s flagship therapeutic, is paving the way for innovation in collaboration with Novotech, a global … See details»
Sen-Jam Pharmaceutical Raises $3.1M to Revolutionize …
Apr 5, 2025 Sen-Jam Pharmaceutical is proud to announce a significant milestone in our mission to transform healthcare as we know it. With an impressive fundraising achievement of … See details»
Sen-Jam Pharmaceutical Answers Surgeon General's
Jun 17, 2025 Sen-Jam Pharmaceutical is a pioneering biotech company transforming the treatment landscape for inflammation and metabolic disorders. Through its proprietary … See details»